166 related articles for article (PubMed ID: 19578736)
1. The role of hepatocyte growth factor activator inhibitor-1 (HAI-1) as a prognostic indicator in cervical cancer.
Nakamura K; Abarzua F; Hongo A; Kodama J; Nasu Y; Kumon H; Hiramatsu Y
Int J Oncol; 2009 Aug; 35(2):239-48. PubMed ID: 19578736
[TBL] [Abstract][Full Text] [Related]
2. Expression of hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) in ovarian cancer.
Nakamura K; Abarzua F; Kodama J; Hongo A; Nasu Y; Kumon H; Hiramatsu Y
Int J Oncol; 2009 Feb; 34(2):345-53. PubMed ID: 19148468
[TBL] [Abstract][Full Text] [Related]
3. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters.
Oberst MD; Johnson MD; Dickson RB; Lin CY; Singh B; Stewart M; Williams A; al-Nafussi A; Smyth JF; Gabra H; Sellar GC
Clin Cancer Res; 2002 Apr; 8(4):1101-7. PubMed ID: 11948120
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer.
Nakamura K; Abarzua F; Hongo A; Kodama J; Nasu Y; Kumon H; Hiramatsu Y
Ann Oncol; 2009 Jan; 20(1):63-70. PubMed ID: 18689863
[TBL] [Abstract][Full Text] [Related]
5. Serum hepatocyte growth factor activator inhibitor type I (HAI-I) and type 2 (HAI-2) in prostate cancer.
Nagakawa O; Yamagishi T; Akashi T; Nagaike K; Fuse H
Prostate; 2006 Apr; 66(5):447-52. PubMed ID: 16353247
[TBL] [Abstract][Full Text] [Related]
6. The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer.
Nakamura K; Hongo A; Kodama J; Hiramatsu Y
Int J Cancer; 2011 Jun; 128(11):2613-24. PubMed ID: 20715109
[TBL] [Abstract][Full Text] [Related]
7. [Expression of Notch intracellular domain in cervical cancer and effect of DAPT on cervical cancer cell].
Sun XM; Wen HW; Chen CL; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2009 May; 44(5):369-73. PubMed ID: 19573314
[TBL] [Abstract][Full Text] [Related]
8. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.
Cheng H; Fukushima T; Takahashi N; Tanaka H; Kataoka H
Cancer Res; 2009 Mar; 69(5):1828-35. PubMed ID: 19223533
[TBL] [Abstract][Full Text] [Related]
10. Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis.
Li W; Wang BE; Moran P; Lipari T; Ganesan R; Corpuz R; Ludlam MJ; Gogineni A; Koeppen H; Bunting S; Gao WQ; Kirchhofer D
Cancer Res; 2009 Nov; 69(21):8395-402. PubMed ID: 19843851
[TBL] [Abstract][Full Text] [Related]
11. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
12. Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.
Baba T; Kawaguchi M; Fukushima T; Sato Y; Orikawa H; Yorita K; Tanaka H; Lin CY; Sakoda S; Kataoka H
J Pathol; 2012 Oct; 228(2):181-92. PubMed ID: 22262311
[TBL] [Abstract][Full Text] [Related]
13. [Effect of HAI-1 over-expression on in vitro growth and migration/motility of SW620 cells].
Cao J; Ye JJ
Shi Yan Sheng Wu Xue Bao; 2005 Jun; 38(3):183-9. PubMed ID: 16044910
[TBL] [Abstract][Full Text] [Related]
14. [mRNA expression of basic fibroblast growth factor and hepatocyte growth factor in gastric carcinoma and significance thereof].
Ru GQ; Zhao ZS; Tang QL; Xu WJ
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2030-5. PubMed ID: 19080429
[TBL] [Abstract][Full Text] [Related]
15. Expression of hepatocyte growth factor activator inhibitor-1 (HAI-1) gene in prostate cancer: clinical and biological significance.
Hu C; Jiang N; Wang G; Zheng J; Yang W; Yang J
J BUON; 2014; 19(1):215-20. PubMed ID: 24659667
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
Parr C; Jiang WG
Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
[TBL] [Abstract][Full Text] [Related]
17. Expression of Hepatocyte growth factor activator inhibitor type-1 (HAI-1) in prostate cancer.
Yasuda K; Komiya A; Watanabe A; Morii A; Oya T; Nagakawa O; Fujiuchi Y; Fuse H
Anticancer Res; 2013 Feb; 33(2):575-81. PubMed ID: 23393351
[TBL] [Abstract][Full Text] [Related]
18. Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Tamaya T
BMC Cancer; 2008 Oct; 8():301. PubMed ID: 18937843
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of cystic fibrosis transmembrane conductance regulator (CFTR) is associated with human cervical cancer malignancy, progression and prognosis.
Peng X; Wu Z; Yu L; Li J; Xu W; Chan HC; Zhang Y; Hu L
Gynecol Oncol; 2012 May; 125(2):470-6. PubMed ID: 22366595
[TBL] [Abstract][Full Text] [Related]
20. Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.
Kirchhofer D; Peek M; Lipari MT; Billeci K; Fan B; Moran P
FEBS Lett; 2005 Mar; 579(9):1945-50. PubMed ID: 15792801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
